Diagnosticos da America (DASA3) Stock Overview

Diagnósticos da América S.A. provides diagnostic and hospital services in Latin America. It offers medical and outpatient services; outpatient physician services; diagnostic support assistants for private patients or covered companies; care coordination, remote monitoring, population health management, service home medical, and paramedical services; and medical consultations and outpatient medical services. The company is also involved in the development and licensing of computer programs, as well as predictive models using information technology and data science; and brokerage activities. In addition, it provides imaging, clinical analysis, vaccine, and advisory services; and chemotherapy treatment services, including outpatient procedures and examinations, medical consultations related to oncology care lines, oncology outpatient treatment, and oncology surgeries. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in Barueri, Brazil.